Skip to content
lifestyle.cleanweb.co
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
CDT Equity Inc.
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
April 30, 2026
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth
April 29, 2026
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence
April 28, 2026
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
March 5, 2026
CDT Positions for Transformational Growth
March 4, 2026
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals
February 24, 2026
←
Previous Page
1
2